Dermatology offices spend ~13 hours weekly on prior authorizations, file ~39 requests per physician annually, and see roughly one-third denied, creating operational costs and delayed initiation of ...
Use of automated insulin delivery technology improves a Healthcare Effectiveness Data and Information Set quality measure in ...
Workforce expansion authorized after the 2024 Harlem outbreak remains incomplete, with 35 staff onboard versus a planned 56, leaving gaps in inspection and response throughput. A second lethal cluster ...
FDA approved zidesamtinib for previously treated ROS1+ locally advanced/metastatic NSCLC, marking GSK’s entry into approved lung cancer therapeutics following acquisition of Nuvalent’s portfolio. ROS1 ...
A multiyear “tariff cliff” sets 0% through July 2028, then 100% for one year and 200% thereafter, explicitly tying penalties to failure to establish US manufacturing capacity. Sparse implementation ...
CARDIO-TTRansform randomized 1432 wild-type or hereditary ATTR-CM patients to eplontersen 45 mg vs placebo every 4 weeks, with a primary composite endpoint assessed through week 140. Real-world ...
Mean LDL-C at 6 months was 76.3 vs 85.6 mg/dL, yielding an adjusted difference of −6.62 mg/dL and higher attainment of LDL-C <50 mg/dL. Intervention uptake increased intensive and combination ...
Subcutaneous checkpoint inhibitors drove up volume and forced staffing changes, according to Angie Maynard, PharmD, MS, and ...
Cardiovascular (cMRI) identified that left bundle branch block (LBBB) does not significantly alter left atrial (LA) strain ...
Treatment-refractory generalized MG (~11% in a strict Austrian cohort) is associated with frequent exacerbations, rescue therapy needs, escalated immunosuppression, and sustained disability, ...
Deepak Bhatt, MD, MPH, MBA, discusses how new evidence, prevention definitions, and imaging advances are reshaping how PCSK9 ...
Neurologist scarcity, especially in under-resourced communities, remains a central structural barrier to timely multiple sclerosis diagnosis and longitudinal disease management. Heterogeneous ...